These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Renal Amyloidosis: Presentation, Diagnosis, and Management. Gurung R; Li T Am J Med; 2022 Apr; 135 Suppl 1():S38-S43. PubMed ID: 35085515 [TBL] [Abstract][Full Text] [Related]
30. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know]. Arbustini E; Gavazzi A; Merlini G Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807 [TBL] [Abstract][Full Text] [Related]
35. Cardiac transplantation for amyloid heart disease: the United Kingdom experience. Dubrey SW; Burke MM; Hawkins PN; Banner NR J Heart Lung Transplant; 2004 Oct; 23(10):1142-53. PubMed ID: 15477107 [TBL] [Abstract][Full Text] [Related]
36. Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis. Said SM; Sethi S; Valeri AM; Chang A; Nast CC; Krahl L; Molloy P; Barry M; Fidler ME; Cornell LD; Leung N; Vrana JA; Theis JD; Dogan A; Nasr SH Kidney Int; 2014 Aug; 86(2):370-7. PubMed ID: 24451324 [TBL] [Abstract][Full Text] [Related]
37. Successful hepatorenal transplantation in hereditary amyloidosis caused by a frame-shift mutation in fibrinogen Aalpha-chain gene. Mousson C; Heyd B; Justrabo E; Rebibou JM; Tanter Y; Miguet JP; Rifle G Am J Transplant; 2006 Mar; 6(3):632-5. PubMed ID: 16468976 [TBL] [Abstract][Full Text] [Related]
38. Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen alpha-chain variant in an English family. Gillmore JD; Booth DR; Rela M; Heaton ND; Rahman V; Stangou AJ; Pepys MB; Hawkins PN QJM; 2000 May; 93(5):269-75. PubMed ID: 10825402 [TBL] [Abstract][Full Text] [Related]
39. Long term outcome of renal allografts in patients with immunoglobulin A nephropathy. Ng YS; Vathsala A; Chew ST; Chiang GS; Woo KT Med J Malaysia; 2007 Jun; 62(2):109-13. PubMed ID: 18705440 [TBL] [Abstract][Full Text] [Related]